115th Congress (2017–2019) · Senate bill · Sponsor: Sen. Collins, Susan M. [R-ME]
This page covers S2554 in the 115th Congress. Bill numbers start over every Congress, so S2554 in another Congress is a different bill.
| Item | Detail |
|---|---|
| Roll-call votes | 1 |
| Chamber | Senate |
| Latest vote | 2018-09-17: Bill Passed (98-2) |
| Latest action | 2018-10-10: Became Public Law No: 115-263. |
| Policy area | Health |
| Official record | Congress.gov |
Patient Right to Know Drug Prices Act (Sec. 2) This bill amends the Public Health Service Act to prohibit a health insurance plan or pharmacy benefits manager from restricting a pharmacy from informing an enrollee of any difference between the out-of-pocket cost of a drug under the plan and the cost of the drug without health insurance coverage. (Such restrictions are commonly referred to as gag clauses.) (Sec. 3) The bill also amends the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 to apply certain antitrust filing requirements for generic drug applicants to biosimilar biological product applicants. (Biosimilar biological products, commonly referred to as biosimilars, are biological products approved by the Food and Drug Administration based on their similarity to an already-approved biological product.) Under current law, generic drug applicants that make agreements with brand name drug companies or other generic drug applicants regarding the manufacture, marketing, or sale of their drugs must file such agreements with the Federal Trade Commission and the Department of Justice. The bill subjects biosimilar biological product applicants to the same filing requirements.
Subjects: Civil actions and liability, Drug safety, medical device, and laboratory regulation, Health care costs and insurance, Health care coverage and access, Inflation and prices, Prescription drugs
Every recorded vote on this bill, newest first, with a link to the official tally. Member-by-member positions are on each member’s profile.
| Date | Chamber | Question | Result | Yea | Nay | Not voting | Record |
|---|---|---|---|---|---|---|---|
| 2018-09-17 | Senate | On Passage of the Bill S. 2554 | Bill Passed (98-2) | 64 | 2 | 0 | Official tally |
S2554 (Patient Right to Know Drug Prices Act) was introduced in the 115th Congress (2017–2019) by Sen. Collins, Susan M. [R-ME].
On 2018-10-10: Became Public Law No: 115-263.
1 recorded vote in the 115th Congress. The most recent, on 2018-09-17, was "On Passage of the Bill S. 2554": Bill Passed (98-2).